KRAS and cancer: Moreover, we show that this cell death process, induced by the treatment with Complex I inhibitors, is activated also in other three cancer cell lines, mouse K-ras transformed fibroblasts, human MIA PaCa-2 pancreatic cancer cells, and human A549 lung adenocarcinoma cells.